2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
暂无分享,去创建一个
S. Tu | Weili Zhao | Jianxiang Wang | Depei Wu | Jun Zhu | X. Ke | Bin Zhang | A. Liang | W. Han | Yongping Song | Kailin Xu | Xiaojun Huang | He Huang | T. Niu | H. Jing | Yun Liang | H. Mei | Sujun Gao | Ping Li | Liang Huang | Zhao Wang | Yong-xian Hu | Fengxia Shi | Yang Liu | Ya-jing Zhang | L. Su | P. Lu | Qing-ming Yang | Z. Ying | Yuhua Li | Xiangyu Zhao | Wenbin Qian | Yuqin Song | Yu Hu | Huilai Zhang | Mingfeng Zhao | Qi-fa Liu | Xi Zhang | Jian Bo | Jianyong Li | K. Xu | Yajing Zhang | F. Shi